{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:46:17Z","timestamp":1780472777690,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Special Disease Construction Project of Jiading District Health System","award":["ZK2024A08"],"award-info":[{"award-number":["ZK2024A08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02768-w","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:58:44Z","timestamp":1748541524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From infection to tumor: genetic evidence of viral antibody immune response\u2019 role in urologic cancer development"],"prefix":"10.1007","volume":"16","author":[{"given":"Chen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"3","key":"2768_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2768_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1158\/1055-9965.EPI-21-0797","volume":"31","author":"C Radkiewicz","year":"2022","unstructured":"Radkiewicz C, et al. Declining cancer incidence in the elderly: Decreasing diagnostic intensity or biology? Cancer Epidemiol Biomark Prev. 2022;31(1):280\u20136.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2768_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semcancer.2023.03.002","volume":"91","author":"G Papavasileiou","year":"2023","unstructured":"Papavasileiou G, et al. Obesity and main urologic cancers: current systematic evidence, novel biological mechanisms, perspectives and challenges. Semin Cancer Biol. 2023;91:70\u201398.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"2768_CR4","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"B Escudier","year":"2019","unstructured":"Escudier B, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-updagger. Ann Oncol. 2019;30(5):706\u201320.","journal-title":"Ann Oncol"},{"issue":"1","key":"2768_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","volume":"20","author":"RJ Motzer","year":"2022","unstructured":"Motzer RJ, et al. Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(1):71\u201390.","journal-title":"J Natl Compr Canc Netw"},{"key":"2768_CR6","doi-asserted-by":"publisher","first-page":"1071030","DOI":"10.3389\/fonc.2023.1071030","volume":"13","author":"P Su","year":"2023","unstructured":"Su P, Zhang M, Kang X. Targeting c-Met in the treatment of urologic neoplasms: current status and challenges. Front Oncol. 2023;13:1071030.","journal-title":"Front Oncol"},{"issue":"1","key":"2768_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s11658-023-00442-z","volume":"28","author":"S Li","year":"2023","unstructured":"Li S, et al. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer. Cell Mol Biol Lett. 2023;28(1):28.","journal-title":"Cell Mol Biol Lett"},{"issue":"6","key":"2768_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","volume":"13","author":"C de Martel","year":"2012","unstructured":"de Martel C, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607\u201315.","journal-title":"Lancet Oncol"},{"issue":"7","key":"2768_CR9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3201\/eid1207.060037","volume":"12","author":"SM O'Connor","year":"2006","unstructured":"O\u2019Connor SM, Taylor CE, Hughes JM. Emerging infectious determinants of chronic diseases. Emerg Infect Dis. 2006;12(7):1051\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"2768_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuron.2018.05.023","volume":"99","author":"B Readhead","year":"2018","unstructured":"Readhead B, et al. Multiscale analysis of independent alzheimer\u2019s cohorts finds disruption of molecular genetic and clinical networks by human herpesvirus. Neuron. 2018;99(1):64\u201382.","journal-title":"Neuron"},{"issue":"1","key":"2768_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","volume":"28","author":"B Foxman","year":"2014","unstructured":"Foxman B. Urinary tract infection syndromes. Infect Dis Clin N Am. 2014;28(1):1\u201313.","journal-title":"Infect Dis Clin N Am"},{"issue":"2","key":"2768_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/1078-0432.CCR-08-0149","volume":"15","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, Long-Term Foe. Clin Cancer Res. 2009;15(2):425\u201330.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2768_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.semcancer.2004.06.006","volume":"14","author":"M Philip","year":"2004","unstructured":"Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol. 2004;14(6):433\u20139.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"2768_CR14","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.eururo.2020.11.041","volume":"79","author":"G Mantica","year":"2021","unstructured":"Mantica G, Terrone C, Der Merwe AV. Bladder cancer and associated risk factors: the african panorama. Eur Urol. 2021;79(5):568\u201370.","journal-title":"Eur Urol"},{"issue":"10","key":"2768_CR15","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.3390\/jcm9103195","volume":"9","author":"P Kryst","year":"2020","unstructured":"Kryst P, et al. Epstein-Barr virus and human adenovirus viremia in renal tumors is associated with histological features of malignancy. J Clin Med. 2020;9(10):3195.","journal-title":"J Clin Med"},{"issue":"3","key":"2768_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41588-019-0558-9","volume":"52","author":"M Zapatka","year":"2020","unstructured":"Zapatka M, et al. The landscape of viral associations in human cancers. Nat Genet. 2020;52(3):320\u201330.","journal-title":"Nat Genet"},{"issue":"4","key":"2768_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/bmjebm-2022-112149","volume":"28","author":"MS Kim","year":"2023","unstructured":"Kim MS, et al. How to interpret studies using Mendelian randomisation. BMJ Evid Based Med. 2023;28(4):251\u20134.","journal-title":"BMJ Evid Based Med"},{"key":"2768_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess S, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2019;4:186.","journal-title":"Wellcome Open Res"},{"issue":"7944","key":"2768_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature"},{"issue":"20","key":"2768_CR20","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","volume":"32","author":"JR Staley","year":"2016","unstructured":"Staley JR, et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics. 2016;32(20):3207\u20139.","journal-title":"Bioinformatics"},{"issue":"3","key":"2768_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40(3):740\u201352.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"2768_CR22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755\u201364.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"2768_CR23","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/diagnostics11050908","volume":"11","author":"F Crocetto","year":"2021","unstructured":"Crocetto F, et al. BRCA germline mutations in prostate cancer: the future is tailored. Diagnostics. 2021;11(5):908.","journal-title":"Diagnostics"},{"issue":"4","key":"2768_CR24","doi-asserted-by":"publisher","first-page":"FSO674","DOI":"10.2144\/fsoa-2020-0210","volume":"7","author":"F Crocetto","year":"2021","unstructured":"Crocetto F, et al. Urologic malignancies: advances in the analysis and interpretation of clinical findings. Future Sci OA. 2021;7(4):FSO674.","journal-title":"Future Sci OA"},{"issue":"5","key":"2768_CR25","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.2353\/ajpath.2007.061026","volume":"170","author":"H-C Chuang","year":"2007","unstructured":"Chuang H-C, et al. Epstein-Barr Virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-\u03b1 (TNF-\u03b1) receptor-1 and confers resistance to TNF-\u03b1-Induced apoptosis in T cells. Am J Pathol. 2007;170(5):1607\u201317.","journal-title":"Am J Pathol"},{"issue":"6","key":"2768_CR26","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.3892\/or.2015.4305","volume":"34","author":"L Sun","year":"2015","unstructured":"Sun L, et al. LMP1 promotes nasal NK\/T-cell lymphoma cell function by eIF4E via NF-kappaB pathway. Oncol Rep. 2015;34(6):3264\u201371.","journal-title":"Oncol Rep"},{"issue":"6","key":"2768_CR27","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s41375-018-0324-5","volume":"33","author":"RJ Peng","year":"2019","unstructured":"Peng RJ, et al. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma. Leukemia. 2019;33(6):1451\u201362.","journal-title":"Leukemia"},{"issue":"11","key":"2768_CR28","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s00262-022-03183-8","volume":"71","author":"M Prasad","year":"2022","unstructured":"Prasad M, et al. Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors. Cancer Immunol Immunother. 2022;71(11):2583\u201396.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"2768_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41392-021-00820-z","volume":"7","author":"Z Wang","year":"2022","unstructured":"Wang Z, et al. Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunction. Signal Transduct Target Ther. 2022;7(1):19.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2768_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27\u201341.","journal-title":"Immunity"},{"issue":"13","key":"2768_CR31","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1084\/jem.20081165","volume":"205","author":"V Urbonaviciute","year":"2008","unstructured":"Urbonaviciute V, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med. 2008;205(13):3007\u201318.","journal-title":"J Exp Med"},{"issue":"9","key":"2768_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.120","volume":"3","author":"M Baritaud","year":"2012","unstructured":"Baritaud M, et al. AIF-mediated caspase-independent necroptosis requires ATM and DNA-PK-induced histone H2AX Ser139 phosphorylation. Cell Death Dis. 2012;3(9): e390.","journal-title":"Cell Death Dis"},{"issue":"2","key":"2768_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","volume":"15","author":"S Grivennikov","year":"2009","unstructured":"Grivennikov S, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15(2):103\u201313.","journal-title":"Cancer Cell"},{"issue":"9","key":"2768_CR34","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.7150\/ijbs.4614","volume":"8","author":"MJ Waldner","year":"2012","unstructured":"Waldner MJ, Foersch S, Neurath MF. Interleukin-6\u2013a key regulator of colorectal cancer development. Int J Biol Sci. 2012;8(9):1248\u201353.","journal-title":"Int J Biol Sci"},{"issue":"27","key":"2768_CR35","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1038\/onc.2014.286","volume":"34","author":"V De Simone","year":"2015","unstructured":"De Simone V, et al. Th17-type cytokines, IL-6 and TNF-alpha synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene. 2015;34(27):3493\u2013503.","journal-title":"Oncogene"},{"issue":"10","key":"2768_CR36","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1172\/JCI42754","volume":"121","author":"H Ijichi","year":"2011","unstructured":"Ijichi H, et al. Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. J Clin Investig. 2011;121(10):4106\u201317.","journal-title":"J Clin Investig"},{"issue":"15","key":"2768_CR37","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.3390\/nu14153065","volume":"14","author":"A Frum","year":"2022","unstructured":"Frum A, et al. Valorization of grape pomace and berries as a new and sustainable dietary supplement: development, characterization, and antioxidant activity testing. Nutrients. 2022;14(15):3065.","journal-title":"Nutrients"},{"issue":"13","key":"2768_CR38","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.3390\/molecules27134215","volume":"27","author":"M Karkoszka","year":"2022","unstructured":"Karkoszka M, et al. The assessment of meloxicam phototoxicity in human normal skin cells: in vitro studies on dermal fibroblasts and epidermal melanocytes. Molecules. 2022;27(13):4215.","journal-title":"Molecules"},{"key":"2768_CR39","doi-asserted-by":"publisher","first-page":"824179","DOI":"10.3389\/fvets.2021.824179","volume":"8","author":"L Kong","year":"2022","unstructured":"Kong L, et al. Infectious bronchitis virus infection increases pathogenicity of h9n2 avian influenza virus by inducing severe inflammatory response. Front Vet Sci. 2022;8:824179.","journal-title":"Front Vet Sci"},{"issue":"6","key":"2768_CR40","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.7150\/thno.70277","volume":"12","author":"B Zhou","year":"2022","unstructured":"Zhou B, et al. Antibacterial PDT nanoplatform capable of releasing therapeutic gas for synergistic and enhanced treatment against deep infections. Theranostics. 2022;12(6):2580\u201397.","journal-title":"Theranostics"},{"issue":"1","key":"2768_CR41","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1038\/s41598-017-03656-2","volume":"7","author":"Y Pan","year":"2017","unstructured":"Pan Y, et al. Streptococcus sp. in neonatal endotracheal tube biofilms is associated with ventilator-associated pneumonia and enhanced biofilm formation of Pseudomonas aeruginosa PAO1. Sci Rep. 2017;7(1):3423.","journal-title":"Sci Rep"},{"issue":"1","key":"2768_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13045-023-01405-9","volume":"16","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, et al. Exploiting RIG-I-like receptor pathway for cancer immunotherapy. J Hematol Oncol. 2023;16(1):8.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"2768_CR43","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.2174\/138920112800958913","volume":"13","author":"AW Tong","year":"2012","unstructured":"Tong AW, et al. Oncolytic viruses for induction of anti-tumor immunity. Curr Pharm Biotechnol. 2012;13(9):1750\u201360.","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"2768_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1158\/0008-5472.CAN-14-2533","volume":"75","author":"E Galanis","year":"2015","unstructured":"Galanis E, et al. Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer. Cancer Res. 2015;75(1):22\u201330.","journal-title":"Cancer Res"},{"key":"2768_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cytogfr.2018.03.006","volume":"41","author":"JF de Graaf","year":"2018","unstructured":"de Graaf JF, et al. Armed oncolytic viruses: a kick-start for anti-tumor immunity. Cytokine Growth Factor Rev. 2018;41:28\u201339.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"2768_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1407897","volume":"7","author":"T Delaunay","year":"2018","unstructured":"Delaunay T, et al. Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells. Oncoimmunology. 2018;7(3): e1407897.","journal-title":"Oncoimmunology"},{"issue":"25","key":"2768_CR47","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","volume":"33","author":"RH Andtbacka","year":"2015","unstructured":"Andtbacka RH, et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol. 2015;33(25):2780\u20138.","journal-title":"J Clin Oncol"},{"issue":"9","key":"2768_CR48","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrd4663","volume":"14","author":"HL Kaufman","year":"2015","unstructured":"Kaufman HL, Kohlhapp FJ, Zloza A. Oncolytic viruses: a new class of immunotherapy drugs. Nat Rev Drug Discovery. 2015;14(9):642\u201362.","journal-title":"Nat Rev Drug Discovery"},{"issue":"6","key":"2768_CR49","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1001\/jamaoncol.2016.2064","volume":"3","author":"SE Lawler","year":"2017","unstructured":"Lawler SE, et al. Oncolytic viruses in cancer treatment: a review. JAMA Oncol. 2017;3(6):841\u20139.","journal-title":"JAMA Oncol"},{"issue":"4","key":"2768_CR50","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ccell.2018.03.011","volume":"33","author":"SJ Russell","year":"2018","unstructured":"Russell SJ, Barber GN. Oncolytic viruses as antigen-agnostic cancer vaccines. Cancer Cell. 2018;33(4):599\u2013605.","journal-title":"Cancer Cell"},{"issue":"18","key":"2768_CR51","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.3390\/cells11182858","volume":"11","author":"JA Minott","year":"2022","unstructured":"Minott JA, et al. The role of neutrophils in oncolytic orf virus-mediated cancer immunotherapy. Cells. 2022;11(18):2858.","journal-title":"Cells"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02768-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02768-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02768-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T19:04:00Z","timestamp":1748545440000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02768-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2768"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02768-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Local laws and institutional policies did not require written informed consent for this study. According to national laws and institutional policies, the study did not require ethical approval or consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"947"}}